Cargando…
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Gastric cancer (GC) is the fifth most common cancer worldwide. Despite recent improvements in treatment quality and options, advanced gastric cancer remains one of the hardest to cure cancers, with a median overall survival (OS) of 10–12 months and a 5-year OS of approximately 5–20%. There is an unm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286155/ https://www.ncbi.nlm.nih.gov/pubmed/34285507 http://dx.doi.org/10.2147/OTT.S315252 |